These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23343154)

  • 21. [Formulation of new generation drug delivery system for dry powder inhalation.].
    Chvatal A; Szabo B; Szabo-Revesz P; Ambrus R
    Acta Pharm Hung; 2016; 86(3):75-83. PubMed ID: 29489079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of device resistance and inhalation flow rate on the lung deposition of orally inhaled mannitol dry powder.
    Yang MY; Verschuer J; Shi Y; Song Y; Katsifis A; Eberl S; Wong K; Brannan JD; Cai W; Finlay WH; Chan HK
    Int J Pharm; 2016 Nov; 513(1-2):294-301. PubMed ID: 27639621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-use disposable dry powder inhalers for pulmonary drug delivery.
    Friebel C; Steckel H
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1359-72. PubMed ID: 21080859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary drug delivery: medicines for inhalation.
    Henning A; Hein S; Schneider M; Bur M; Lehr CM
    Handb Exp Pharmacol; 2010; (197):171-92. PubMed ID: 20217530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of radiolabeling of drug formulations for aerosol deposition assessment of orally inhaled products.
    Devadason SG; Chan HK; Haeussermann S; Kietzig C; Kuehl PJ; Newman S; Sommerer K; Taylor G
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25 Suppl 1():S6-9. PubMed ID: 23215848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation.
    Pozzoli M; Rogueda P; Zhu B; Smith T; Young PM; Traini D; Sonvico F
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1660-8. PubMed ID: 26953090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dry powder inhalers for pulmonary drug delivery.
    Frijlink HW; De Boer AH
    Expert Opin Drug Deliv; 2004 Nov; 1(1):67-86. PubMed ID: 16296721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug delivery to the Lungs 21.
    Mitchell JP; Nichols SC
    Ther Deliv; 2011 Mar; 2(3):301-5. PubMed ID: 22834000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin inhalation--Pfizer/Nektar Therapeutics: HMR 4006, inhaled PEG-insulin--Nektar, PEGylated insulin--Nektar.
    Drugs R D; 2004; 5(3):166-70. PubMed ID: 15139780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate.
    Grasmeijer F; de Boer AH
    Int J Pharm; 2014 Apr; 465(1-2):165-8. PubMed ID: 24548720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inhalation of drugs: advantages and problems.
    Rau JL
    Respir Care; 2005 Mar; 50(3):367-82. PubMed ID: 15737247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of disposable inhalers in pulmonary drug delivery.
    de Boer AH; Hagedoorn P
    Expert Opin Drug Deliv; 2015 Jan; 12(1):143-57. PubMed ID: 25374325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial: Emerging Formulation Design and Drug Delivery Systems for Inhaled Therapy.
    Chan HK; Zhou QT
    Curr Pharm Des; 2015; 21(27):3852-3. PubMed ID: 26295951
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose emission characteristics of placebo PulmoSphere® particles are unaffected by a subject's inhalation maneuver.
    Weers J; Ung K; Le J; Rao N; Ament B; Axford G; Maltz D; Chan L
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):56-68. PubMed ID: 22691109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges for pulmonary delivery of high powder doses.
    Sibum I; Hagedoorn P; de Boer AH; Frijlink HW; Grasmeijer F
    Int J Pharm; 2018 Sep; 548(1):325-336. PubMed ID: 29991452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propellant-driven metered-dose inhalers for pulmonary drug delivery.
    Smyth HD
    Expert Opin Drug Deliv; 2005 Jan; 2(1):53-74. PubMed ID: 16296735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing.
    Delvadia RR; Wei X; Longest PW; Venitz J; Byron PR
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):196-206. PubMed ID: 26447531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.